• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    54.67 Down 1.16(2.08%) Jan 23, 4:00PM EST
    |After Hours : 55.83 Up 1.16 (2.12%) Jan 23, 4:16PM EST
    Add to Portfolio
    Prev Close:55.83
    Open:56.00
    Bid:N/A
    Ask:57.00 x 100
    1y Target Est:84.80
    Beta:1.85
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:54.14 - 56.14
    52wk Range:41.99 - 80.42
    Volume:237,706
    Avg Vol (3m):286,455
    Market Cap:1.09B
    P/E (ttm):165.67
    EPS (ttm):0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 2.08%1.09B
    LLYDown 0.46%77.15B
    MRKDown 0.16%178.15B
    RHHBYUp 1.82%N/A

    Key Statistics

    Forward P/E (1 yr):23.77
    P/S (ttm):19.86
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-14) :1.53
    Quarterly EPS Est (Dec-14) :0.60
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.76

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback